153 related articles for article (PubMed ID: 19223558)
1. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.
Chang ET; Birmann BM; Kasperzyk JL; Conti DV; Kraft P; Ambinder RF; Zheng T; Mueller NE
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):976-86. PubMed ID: 19223558
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
3. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China.
Gao J; Xu HL; Gao S; Zhang W; Tan YT; Rothman N; Purdue M; Gao YT; Zheng W; Shu XO; Xiang YB
BMJ Open; 2014 Feb; 4(2):e004427. PubMed ID: 24578542
[TBL] [Abstract][Full Text] [Related]
5. Association of nuclear factor-kappaB in psoriatic arthritis.
Butt C; Sun S; Peddle L; Greenwood C; Hamilton S; Gladman D; Rahman P
J Rheumatol; 2005 Sep; 32(9):1742-4. PubMed ID: 16142871
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study.
Chang ET; Zheng T; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
J Natl Cancer Inst; 2004 Feb; 96(4):305-15. PubMed ID: 14970279
[TBL] [Abstract][Full Text] [Related]
7. SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma.
Gaiolla RD; Moraes MPT; de Oliveira DE
PLoS One; 2021; 16(3):e0248259. PubMed ID: 33684151
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide homozygosity signature and risk of Hodgkin lymphoma.
Sud A; Cooke R; Swerdlow AJ; Houlston RS
Sci Rep; 2015 Sep; 5():14315. PubMed ID: 26391888
[TBL] [Abstract][Full Text] [Related]
9. IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma.
Broderick P; Cunningham D; Vijayakrishnan J; Cooke R; Ashworth A; Swerdlow A; Houlston R
Br J Haematol; 2010 Feb; 148(3):413-5. PubMed ID: 19804451
[TBL] [Abstract][Full Text] [Related]
10. Genetic association study of NF-κB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy.
Chinoy H; Li CK; Platt H; Fertig N; Varsani H; Gunawardena H; Betteridge Z; Oddis CV; McHugh NJ; Wedderburn LR; Ollier WE; Cooper RG;
Rheumatology (Oxford); 2012 May; 51(5):794-9. PubMed ID: 22210660
[TBL] [Abstract][Full Text] [Related]
11. Identification of haplotype tag single nucleotide polymorphisms within the nuclear factor-κB family genes and their clinical relevance in patients with major trauma.
Pan W; Zhang AQ; Gu W; Gao JW; Du DY; Zhang LY; Zeng L; Du J; Wang HY; Jiang JX
Crit Care; 2015 Mar; 19(1):95. PubMed ID: 25880845
[TBL] [Abstract][Full Text] [Related]
12. Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma.
Plantinga TS; Petrulea MS; Oosting M; Joosten LAB; Piciu D; Smit JW; Netea-Maier RT; Georgescu CE
Endocr Relat Cancer; 2017 Jul; 24(7):307-318. PubMed ID: 28428267
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma.
Yri OE; Ekstrøm PO; Hilden V; Gaudernack G; Liestøl K; Smeland EB; Holte H
Leuk Lymphoma; 2012 Oct; 53(10):1934-44. PubMed ID: 22475179
[TBL] [Abstract][Full Text] [Related]
14. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.
Niens M; Jarrett RF; Hepkema B; Nolte IM; Diepstra A; Platteel M; Kouprie N; Delury CP; Gallagher A; Visser L; Poppema S; te Meerman GJ; van den Berg A
Blood; 2007 Nov; 110(9):3310-5. PubMed ID: 17630352
[TBL] [Abstract][Full Text] [Related]
15. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
Butterbach K; Beckmann L; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Boffetta P; Brennan P; Nieters A
Br J Haematol; 2011 May; 153(3):318-33. PubMed ID: 21418178
[TBL] [Abstract][Full Text] [Related]
16. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
[TBL] [Abstract][Full Text] [Related]
17. Body size and risk of Hodgkin's lymphoma by age and gender: a population-based case-control study in Connecticut and Massachusetts.
Li Q; Chang ET; Bassig BA; Dai M; Qin Q; Gao Y; Zhang Y; Zheng T
Cancer Causes Control; 2013 Feb; 24(2):287-95. PubMed ID: 23208661
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study.
Mollaki V; Georgiadis T; Tassidou A; Ioannou M; Daniil Z; Koutsokera A; Papathanassiou AA; Zintzaras E; Vassilopoulos G
J Hum Genet; 2009 Nov; 54(11):655-9. PubMed ID: 19745833
[TBL] [Abstract][Full Text] [Related]
19. NF-κB deregulation in Hodgkin lymphoma.
Weniger MA; Küppers R
Semin Cancer Biol; 2016 Aug; 39():32-9. PubMed ID: 27221964
[TBL] [Abstract][Full Text] [Related]
20. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
